RONDA FREEMAN: Open Payments
NPI 1073001301 · HUEYTOWN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 42 payments from 15 companies in 2025. Trend: 2023 $1,211 · 2024 $1,245 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $103 |
| Novo Nordisk Inc | 5 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Viatris Specialty LLC | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: Kerendia, TRELEGY ELLIPTA, XIFAXAN, Ozempic, YUPELRI, SHINGRIX, MOUNJARO, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
